L-Fucose

L-Fucose

SCHEMBL1458729

C[C@@H](O)[C@@H](O)[C@@H](O)[C@H](O)C=O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
L-Fucose SCHEMBL525352 1.00
L-Fucose SCHEMBL16703726 1.00
L-Fucose SCHEMBL14830475 1.00
L-Fucose SCHEMBL5072536 1.00
L-Fucose SCHEMBL25051 1.00
L-Fucose SCHEMBL3462756 1.00
L-Fucose SCHEMBL466429 1.00
L-Fucose SCHEMBL2597764 1.00
L-Fucose SCHEMBL1746724 1.00
L-Fucose SCHEMBL11347428 1.00

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8642292-B2 Process for producing molecules containing specialized glycan structures PROBIOGEN AG (DE) 2014-02-04 US claimed
US-20120214975-A1 AAD-1 EVENT DAS-40278-9, RELATED TRANSGENIC CORN LINES, AND EVENT-SPECIFIC IDENTIFICATION THEREOF PROBIOGEN AG (DE) 2012-08-23 US claimed
EP-2480671-A1 PROCESS FOR PRODUCING MOLECULES CONTAINING SPECIALIZED GLYCAN STRUCTURES Sandig, Volker (DE) 2012-08-01 EP claimed
WO-2011035884-A1 PROCESS FOR PRODUCING MOLECULES CONTAINING SPECIALIZED GLYCAN STRUCTURES SANDIG VOLKER (DE) 2011-03-31 WO claimed
WO-2025109161-A1 ANTIMICROBIAL COMPOUNDS FROM ROTIFERS OXFORD UNIVERSITY INNOVATION LIMITED (GB) 2025-05-30 WO disclosed
US-11421223-B2 Processes and host cells for genome, pathway, and biomolecular engineering ENEVOLV, INC. (US) 2022-08-23 US disclosed
EP-3341081-B1 USE OF BIFIDOBACTERIUM LONGUM AND AN EXOPOLYSACCHARIDE PRODUCED THEREBY PREC GROUP LIMITED (IE) 2020-11-11 EP disclosed
US-20190309289-A1 PROCESSES AND HOST CELLS FOR GENOME, PATHWAY, AND BIOMOLECULAR ENGINEERING ENEVOLV, INC. 2019-10-10 US disclosed
US-10370654-B2 Processes and host cells for genome, pathway, and biomolecular engineering ENEVOLV, INC. (US) 2019-08-06 US disclosed
US-20180320170-A1 PROCESSES AND HOST CELLS FOR GENOME, PATHWAY, AND BIOMOLECULAR ENGINEERING ENEVOLV, INC. 2018-11-08 US disclosed
US-20180280453-A1 USE OF BIFIDOBACTERIUM LONGUM AND AN EXOPOLYSACCHARIDE PRODUCED THEREBY ALIMENTARY HEALTH LIMITED (IE) 2018-10-04 US disclosed
EP-3341081-A1 USE OF BIFIDOBACTERIUM LONGUM AND AN EXOPOLYSACCHARIDE PRODUCED THEREBY Alimentary Health Limited (IE) 2018-07-04 EP disclosed
US-5541341-A CARBOHYDRATE BASED SURFACTANTS LEVER BROTHERS COMPANY, DIVISION OF CONOPCO, INC. (US) 1996-07-30 US disclosed
WO-1995012219-A1 STABILISED ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND REDOX CELLS AND BATTERIES CONTAINING STABILISED ELECTROLYTE SOLUTIONS UNISEARCH LIMITED (AU) 1995-05-04 WO disclosed
EP-0584200-A1 TRIFLUOROMETHYL ANALOGS OF FUCOSE AND USES THEREOF THE BIOMEMBRANE INSTITUTE (US) 1994-03-02 EP disclosed
US-5210078-A Antitumor, antiinflammatory, autoimmune diseases, oligosaccharide conjugates THE BIOMEMBRANE INSTITUTE (US) 1993-05-11 US disclosed
WO-1992019632-A1 TRIFLUOROMETHYL ANALOGS OF FUCOSE AND USES THEREOF THE BIOMEMBRANE INSTITUTE (US) 1992-11-12 WO disclosed
EP-0173462-B1 ELLIPTICINE DERIVATIVE AND PRODUCTION PROCESS THEREOF SUNTORY LIMITED (JP) 1989-10-25 EP disclosed
US-4698423-A ANTITUMOR AGENTS SUNTORY LIMITED (JP) 1987-10-06 US disclosed
EP-0173462-A2 Ellipticine derivative and production process thereof SUNTORY LIMITED (JP) 1986-03-05 EP disclosed